Source: http://www.phac-aspc.gc.ca/publicat/cig-gci/p01-14-eng.php
Timestamp: 2016-05-24 19:33:45
Document Index: 608167349

Matched Legal Cases: ['art 1', 'art 1', 'art 2', 'art 3', 'art 4', 'art 5', 'art 4', 'art 5']

Contents of immunizing agents available for use in Canada - Part 1 - General Guidelines - Canadian Immunization Guide
Home > Immunization & Vaccines > Canadian Immunization Guide >
Table of Updates (2012-2014)
DCPHO Message NEW
NACI Chair Message NEW
Acknowledgments NEW
Part 1 - Key Immunization Information
Part 2 - Vaccine Safety
Part 3 - Vaccination of Specific Populations
Part 4 - Active Vaccines
Part 5 - Passive Immunizing Agents
National Advisory Committee on Immunization (NACI) Vaccines Currently Approved for Use in Canada NACI Immunization Schedules Abbreviations for Products Available in Canada More on Immunization and Vaccines Canadian Immunization Guide
[Previous] [Table of Contents]
Key Immunization Information
The following tables provide a comprehensive list of contents of immunizing agents available in Canada. Table 1 lists contents of active vaccines and Table 2 lists contents of passive immunizing agents. Vaccine providers should consult the product label, product leaflet, or product monograph for current product information. Manufacturers provide evidence of vaccine safety and efficacy and receive authorization for the immunizing agent only when it is used in accordance with the product monograph available through Health Canada's Drug Product Database.
Table 1: Types and Contents of Vaccines Available for Use in Canada
For current, complete prescribing information vaccine providers should consult the product leaflet or information contained within the product monographs available through Health Canada's Drug Product Database.
Any component in a vaccine may be a potential allergen. This table identifies most common allergens; adjuvants and preservatives may be potential allergens, but this is extremely rare.
Information about the vaccine manufacturer/distributor is available in vaccine specific chapters in Part 4.
(live; inactivated)
Empty boxes indicate that there are no materials of relevance in the product.
Table 1 - Footnote 1
Multi-dose presentation only.
Table 1 - Footnote 2
Smallpox vaccine (dried) is not available for general use.
Table 3 - Footnote 3
Smallpox vaccine (frozen liquid) is not a Health Canada authorized product but will be released under Health Canada's Special Access Program if required.
Act-HIB�
Tetanus toxoid carrier protein
ADACEL�
ADACEL�-POLIO
Tdap-IPV
AGRIFLU�
Medium 199 Hanks
AVAXIM� Pediatric BEXSERO�
Latex in tip cap of syringe
Histidine,
4CMenB
BOOSTRIX�
BOOSTRIX�-POLIO
Latex in plunger stopper of pre-filled syringe
Hydrated sodium chloride
DUKORAL�
Chol-Ecol-O
ENGERIX�-B
TmFootnote 1
PEFootnote 1
ThimerosalFootnote 1
Pediatric dose FLUAD�
Flulaval™ Tetra
FLUMIST�
FLUVIRAL�
Disodium hydrogen phosphate heptahydrate
FLUZONE�
Triton� X-100
Sodium phosphate-buffered isotonic sodium chloride solution
GARDASIL�
HAVRIX�
HAVRIX� 720 JUNIOR HIBERIX�
IMOVAX� Polio
IMOVAX� Rabies
INFANRIX hexa�
Polysorbate 20 and 80
DTaP-HB-IPV-Hib
INFANRIX�-IPV
INFANRIX�-IPV/Hib
Residual formaldehyde
DTaP-IPV-Hib
INFLUVAC�
Chick protein
IXIARO�
Menactra�
Sodium phosphate dibasic (anhydrous)
Men-C-ACYW-DT
Menjugate�
Diphtheria CRM197
toxoid carrier protein
Disodium phosphate heptahydrate
Men-C-C-CRM
MENOMUNE� A/C/Y/W-135
Latex in stopper
Men-P-ACYW-135
MenveoTM
Disodium hydrogen
phosphate bihydrate
Men-C-ACYW-CRM
M-M-R� II
Residual components of chick embryo cell cultures
Medium 199 with Hank's salts
Minimum essential medium (Eagle)
Potassium phosphate dibasic (anhydrous)
NeisVac-C�
Men-C-C-TT
NIMENRIX�
Men-C-ACYW-TT
PEDIACEL�
PNEUMOVAX� 23
SC/IM
Pneu-P-23
Prevnar� 13 IM
Pneu-C-13
PRIORIX�
PRIORIX-TETRA�
PROQUAD™
Monosodium L-glutamate
QUADRACEL�
RabAvert�
Polygeline (gelatin)
PCECV
RECOMBIVAX HB�
Latex in vial stopper
ROTARIX�
Disodium adipate
DNA fragments from porcine circovirus 1
Rot-1
RotaTeq�
DNA fragments from porcine circoviruses 1 and 2
Residual protein from cell culture
Rot-5
Smallpox (dried)Footnote 2
Latex in stopper of vaccine vial
Bovine tissue (trace)
McIlvaine buffer
Smallpox (frozen)Footnote 3
SYNFLORIX�
Latex in syringe components
Diphtheria toxoid carrier protein
Non-typeable Haemophilus influenzae protein D carrier protein
Pneu-C-10
Td ADSORBED
TWINRIX�
TWINRIX� Junior TYPHERIX�
Sodium phosphate dihydrate
Typh-I
TYPHIM Vi�
Isotonic buffer solution
Typh-1
VAQTA�
VARILRIX�
VARIVAX� III
VAXIGRIP�
ViVAXIM�
Typh++
PE CH2O
HA-Typh-I
Vivotif�
Amino acid mixture
Erythrosine FD+C red 3
Hydroxypropylcellulose-phthalate
Typh-O
YF-VAX�
Latex in stopper of diluent vial
ZOSTAVAX�
Route-
Immunogen-
acellular pertussis (reduced)
Bacillus Calmette-Gu�rin
diphtheria (reduced)
inactivated poliomyelitis
Neisseria meningitidis Serogroup B protein
Adjuvant-
aluminum-containing adjuvant
3-O-desacyl-4'-monophosphoryl lipid A adsorbed onto aluminum (as hydroxide salt)
squalene, polysorbate 80, sorbitan trioleate, sodium citrate, citric acid, water for injection
Preservative-
Products with active drug identification numbers (DIN):
The following vaccines are authorized for marketing in Canada but are not generally available:
Epaxal� (Berna Biotech Ltd.)
Liquid Pedvax HIB� (Merck Canada Inc.)
Pentacel� (Sanofi Pasteur Ltd.)
Prevnar� (Pfizer Canada Inc.)
Vivotif� L (Berna Biotech Ltd.)
Zostavax� II (Merck Canada Inc.)
Table 2: Types and Contents of Passive Immunizing Agents Available for Use in Canada
For current, complete prescribing information vaccine providers should consult the product leaflet or information contained within the product monograph available through Health Canada's Drug Product Database.
Information about the passive immunizing agent manufacturer/distributor is available in Passive Immunizing Agents in Part 5.
Passive immunizing
Protects against or treats
ANTIDIPHTHERIA SERUM
Equine protein
Cytogam�
CMVIg
GamaSTAN� S/D
Human plasma protein
HepaGam B�
HyperHEP B� S/D
HYPERRAB� S/D
IM/ -local
RabIg
HYPERTET� S/D
IMOGAM� Rabies Pasteurized
SYNAGIS� (palivizumab)
RSVAb
CNJ-016�
VariZIGTM
IV/ IM
Protects against or treats-
The following passive immunizing agent is authorized in Canada but is not generally available:
Immune Serum Globulin (Human) (Grifols Therapeutics Inc.)
Keith LS, Jones DE, Chou C. Aluminum toxicokinetics regarding infant diet and vaccinations. Vaccine 2002;20:S13-17.
Offit PA, Jew RK. Addressing parents' concerns: Do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics 2003;112:1394-97.
Date Modified: 2016-02-18 Top of Page